Report Scope
This latest report researches the industry structure, revenue and gross margin. Major players headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Animal Antibacterial and Antibiotics companies, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Animal Antibacterial and Antibiotics market. Further, it explains the major drivers and regional dynamics of the global Animal Antibacterial and Antibiotics market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
- Zoetis
- Merck Animal Health
- Merial
- Elanco
- Bayer HealthCare
- Biogénesis Bagó
- Boehringer Ingelheim Vetmedica
- Ceva Santé Animale
- Dechra Pharmaceuticals
- ECO Animal Health
- Huvepharma
- Neogen
- Norbrook
- Orion
- Phibro Animal Health
- Vétoquinol
- Virbac
- Vitafor
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.
Animal Antibacterial and Antibiotics Segment by Type
- Tetracyclines
- Penicillins
- Sulfonamides
- Macrolides
- Aminoglycosides
- Cephalosporins
Animal Antibacterial and Antibiotics Segment by Application
- Livestock
- Pets
- Others
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.
- North America
- - United States
- - Canada
- Europe
- - Germany
- - France
- - UK
- - Italy
- - Russia
- - Nordic Countries
- - Rest of Europe
- Asia-Pacific
- - China
- - Japan
- - South Korea
- - Southeast Asia
- - India
- - Australia
- - Rest of Asia
- Latin America
- - Mexico
- - Brazil
- - Rest of Latin America
- Middle East & Africa
- - Turkey
- - Saudi Arabia
- - UAE
- - Rest of MEA
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Animal Antibacterial and Antibiotics market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Animal Antibacterial and Antibiotics market size. Analyses of the global market trends, with historic market revenue data for 2017 - 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Animal Antibacterial and Antibiotics, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Animal Antibacterial and Antibiotics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Animal Antibacterial and Antibiotics revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Animal Antibacterial and Antibiotics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Animal Antibacterial and Antibiotics revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Zoetis, Merck Animal Health, Merial, Elanco, Bayer HealthCare, Biogénesis Bagó, Boehringer Ingelheim Vetmedica, Ceva Santé Animale and Dechra Pharmaceuticals, etc.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Animal Antibacterial and Antibiotics Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Tetracyclines
1.2.3 Penicillins
1.2.4 Sulfonamides
1.2.5 Macrolides
1.2.6 Aminoglycosides
1.2.7 Cephalosporins
1.3 Market by Application
1.3.1 Global Animal Antibacterial and Antibiotics Market Growth Rate by Application: 2017 VS 2021 VS 2028
1.3.2 Livestock
1.3.3 Pets
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Animal Antibacterial and Antibiotics Market Size (2017-2028)
2.2 Animal Antibacterial and Antibiotics Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.3 Global Animal Antibacterial and Antibiotics Market Size by Region (2017-2022)
2.4 Global Animal Antibacterial and Antibiotics Market Size Forecast by Region (2023-2028)
2.5 Global Top Animal Antibacterial and Antibiotics Countries Ranking by Market Size
3 Animal Antibacterial and Antibiotics Competitive by Company
3.1 Global Animal Antibacterial and Antibiotics Revenue by Players
3.1.1 Global Animal Antibacterial and Antibiotics Revenue by Players (2017-2022)
3.1.2 Global Animal Antibacterial and Antibiotics Market Share by Players (2017-2022)
3.2 Global Animal Antibacterial and Antibiotics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Covered: Ranking by Animal Antibacterial and Antibiotics Revenue
3.4 Global Animal Antibacterial and Antibiotics Market Concentration Ratio
3.4.1 Global Animal Antibacterial and Antibiotics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Animal Antibacterial and Antibiotics Revenue in 2021
3.5 Global Animal Antibacterial and Antibiotics Key Players Head office and Area Served
3.6 Key Players Animal Antibacterial and Antibiotics Product Solution and Service
3.7 Date of Enter into Animal Antibacterial and Antibiotics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Animal Antibacterial and Antibiotics Breakdown Data by Type
4.1 Global Animal Antibacterial and Antibiotics Historic Revenue by Type (2017-2022)
4.2 Global Animal Antibacterial and Antibiotics Forecasted Revenue by Type (2023-2028)
5 Global Animal Antibacterial and Antibiotics Breakdown Data by Application
5.1 Global Animal Antibacterial and Antibiotics Historic Market Size by Application (2017-2022)
5.2 Global Animal Antibacterial and Antibiotics Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Animal Antibacterial and Antibiotics Revenue by Company (2020-2022)
6.2 North America Animal Antibacterial and Antibiotics Revenue by Type (2017-2028)
6.3 North America Animal Antibacterial and Antibiotics Revenue by Application (2017-2028)
6.4 North America Animal Antibacterial and Antibiotics Revenue by Country (2017-2028)
6.4.1 U.S.
6.4.2 Canada
7 Europe
7.1 Europe Animal Antibacterial and Antibiotics Revenue by Company (2020-2022)
7.2 Europe Animal Antibacterial and Antibiotics Revenue by Type (2017-2028)
7.3 Europe Animal Antibacterial and Antibiotics Revenue by Application (2017-2028)
7.4 Europe Animal Antibacterial and Antibiotics Revenue by Country (2017-2028)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
8 Asia Pacific
8.1 Asia Pacific Animal Antibacterial and Antibiotics Revenue by Company (2020-2022)
8.2 Asia Pacific Animal Antibacterial and Antibiotics Revenue by Type (2017-2028)
8.3 Asia Pacific Animal Antibacterial and Antibiotics Revenue by Application (2017-2028)
8.4 Asia Pacific Animal Antibacterial and Antibiotics Revenue by Region (2017-2028)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 India
8.4.5 Australia
8.4.6 Taiwan
8.4.7 Indonesia
8.4.8 Thailand
8.4.9 Malaysia
8.4.10 Philippines
8.4.11 Vietnam
9 Latin America
9.1 Latin America Animal Antibacterial and Antibiotics Revenue by Company (2020-2022)
9.2 Latin America Animal Antibacterial and Antibiotics Revenue by Type (2017-2028)
9.3 Latin America Animal Antibacterial and Antibiotics Revenue by Application (2017-2028)
9.4 Latin America Animal Antibacterial and Antibiotics Revenue by Country (2017-2028)
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Animal Antibacterial and Antibiotics Revenue by Company (2020-2022)
10.2 Middle East and Africa Animal Antibacterial and Antibiotics Revenue by Type (2017-2028)
10.3 Middle East and Africa Animal Antibacterial and Antibiotics Revenue by Application (2017-2028)
10.4 Middle East and Africa Animal Antibacterial and Antibiotics Revenue by Country (2017-2028)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 U.A.E
11 Company Profiles
11.1 Zoetis
11.1.1 Zoetis Company Details
11.1.2 Zoetis Business Overview
11.1.3 Zoetis Animal Antibacterial and Antibiotics Products and Services
11.1.4 Zoetis Animal Antibacterial and Antibiotics Revenue in Animal Antibacterial and Antibiotics Business (2017-2022)
11.1.5 Zoetis Animal Antibacterial and Antibiotics SWOT Analysis
11.1.6 Zoetis Recent Developments
11.2 Merck Animal Health
11.2.1 Merck Animal Health Company Details
11.2.2 Merck Animal Health Business Overview
11.2.3 Merck Animal Health Animal Antibacterial and Antibiotics Products and Services
11.2.4 Merck Animal Health Animal Antibacterial and Antibiotics Revenue in Animal Antibacterial and Antibiotics Business (2017-2022)
11.2.5 Merck Animal Health Animal Antibacterial and Antibiotics SWOT Analysis
11.2.6 Merck Animal Health Recent Developments
11.3 Merial
11.3.1 Merial Company Details
11.3.2 Merial Business Overview
11.3.3 Merial Animal Antibacterial and Antibiotics Products and Services
11.3.4 Merial Animal Antibacterial and Antibiotics Revenue in Animal Antibacterial and Antibiotics Business (2017-2022)
11.3.5 Merial Animal Antibacterial and Antibiotics SWOT Analysis
11.3.6 Merial Recent Developments
11.4 Elanco
11.4.1 Elanco Company Details
11.4.2 Elanco Business Overview
11.4.3 Elanco Animal Antibacterial and Antibiotics Products and Services
11.4.4 Elanco Animal Antibacterial and Antibiotics Revenue in Animal Antibacterial and Antibiotics Business (2017-2022)
11.4.5 Elanco Animal Antibacterial and Antibiotics SWOT Analysis
11.4.6 Elanco Recent Developments
11.5 Bayer HealthCare
11.5.1 Bayer HealthCare Company Details
11.5.2 Bayer HealthCare Business Overview
11.5.3 Bayer HealthCare Animal Antibacterial and Antibiotics Products and Services
11.5.4 Bayer HealthCare Animal Antibacterial and Antibiotics Revenue in Animal Antibacterial and Antibiotics Business (2017-2022)
11.5.5 Bayer HealthCare Animal Antibacterial and Antibiotics SWOT Analysis
11.5.6 Bayer HealthCare Recent Developments
11.6 Biogénesis Bagó
11.6.1 Biogénesis Bagó Company Details
11.6.2 Biogénesis Bagó Business Overview
11.6.3 Biogénesis Bagó Animal Antibacterial and Antibiotics Products and Services
11.6.4 Biogénesis Bagó Animal Antibacterial and Antibiotics Revenue in Animal Antibacterial and Antibiotics Business (2017-2022)
11.6.5 Biogénesis Bagó Animal Antibacterial and Antibiotics SWOT Analysis
11.6.6 Biogénesis Bagó Recent Developments
11.7 Boehringer Ingelheim Vetmedica
11.7.1 Boehringer Ingelheim Vetmedica Company Details
11.7.2 Boehringer Ingelheim Vetmedica Business Overview
11.7.3 Boehringer Ingelheim Vetmedica Animal Antibacterial and Antibiotics Products and Services
11.7.4 Boehringer Ingelheim Vetmedica Animal Antibacterial and Antibiotics Revenue in Animal Antibacterial and Antibiotics Business (2017-2022)
11.7.5 Boehringer Ingelheim Vetmedica Animal Antibacterial and Antibiotics SWOT Analysis
11.7.6 Boehringer Ingelheim Vetmedica Recent Developments
11.8 Ceva Santé Animale
11.8.1 Ceva Santé Animale Company Details
11.8.2 Ceva Santé Animale Business Overview
11.8.3 Ceva Santé Animale Animal Antibacterial and Antibiotics Products and Services
11.8.4 Ceva Santé Animale Animal Antibacterial and Antibiotics Revenue in Animal Antibacterial and Antibiotics Business (2017-2022)
11.8.5 Ceva Santé Animale Animal Antibacterial and Antibiotics SWOT Analysis
11.8.6 Ceva Santé Animale Recent Developments
11.9 Dechra Pharmaceuticals
11.9.1 Dechra Pharmaceuticals Company Details
11.9.2 Dechra Pharmaceuticals Business Overview
11.9.3 Dechra Pharmaceuticals Animal Antibacterial and Antibiotics Products and Services
11.9.4 Dechra Pharmaceuticals Animal Antibacterial and Antibiotics Revenue in Animal Antibacterial and Antibiotics Business (2017-2022)
11.9.5 Dechra Pharmaceuticals Animal Antibacterial and Antibiotics SWOT Analysis
11.9.6 Dechra Pharmaceuticals Recent Developments
11.10 ECO Animal Health
11.10.1 ECO Animal Health Company Details
11.10.2 ECO Animal Health Business Overview
11.10.3 ECO Animal Health Animal Antibacterial and Antibiotics Products and Services
11.10.4 ECO Animal Health Animal Antibacterial and Antibiotics Revenue in Animal Antibacterial and Antibiotics Business (2017-2022)
11.10.5 ECO Animal Health Animal Antibacterial and Antibiotics SWOT Analysis
11.10.6 ECO Animal Health Recent Developments
11.11 Huvepharma
11.11.1 Huvepharma Company Details
11.11.2 Huvepharma Business Overview
11.11.3 Huvepharma Animal Antibacterial and Antibiotics Products and Services
11.11.4 Huvepharma Animal Antibacterial and Antibiotics Revenue in Animal Antibacterial and Antibiotics Business (2017-2022)
11.11.5 Huvepharma Recent Developments
11.12 Neogen
11.12.1 Neogen Company Details
11.12.2 Neogen Business Overview
11.12.3 Neogen Animal Antibacterial and Antibiotics Products and Services
11.12.4 Neogen Animal Antibacterial and Antibiotics Revenue in Animal Antibacterial and Antibiotics Business (2017-2022)
11.12.5 Neogen Recent Developments
11.13 Norbrook
11.13.1 Norbrook Company Details
11.13.2 Norbrook Business Overview
11.13.3 Norbrook Animal Antibacterial and Antibiotics Products and Services
11.13.4 Norbrook Animal Antibacterial and Antibiotics Revenue in Animal Antibacterial and Antibiotics Business (2017-2022)
11.13.5 Norbrook Recent Developments
11.14 Orion
11.14.1 Orion Company Details
11.14.2 Orion Business Overview
11.14.3 Orion Animal Antibacterial and Antibiotics Products and Services
11.14.4 Orion Animal Antibacterial and Antibiotics Revenue in Animal Antibacterial and Antibiotics Business (2017-2022)
11.14.5 Orion Recent Developments
11.15 Phibro Animal Health
11.15.1 Phibro Animal Health Company Details
11.15.2 Phibro Animal Health Business Overview
11.15.3 Phibro Animal Health Animal Antibacterial and Antibiotics Products and Services
11.15.4 Phibro Animal Health Animal Antibacterial and Antibiotics Revenue in Animal Antibacterial and Antibiotics Business (2017-2022)
11.15.5 Phibro Animal Health Recent Developments
11.16 Vétoquinol
11.16.1 Vétoquinol Company Details
11.16.2 Vétoquinol Business Overview
11.16.3 Vétoquinol Animal Antibacterial and Antibiotics Products and Services
11.16.4 Vétoquinol Animal Antibacterial and Antibiotics Revenue in Animal Antibacterial and Antibiotics Business (2017-2022)
11.16.5 Vétoquinol Recent Developments
11.17 Virbac
11.17.1 Virbac Company Details
11.17.2 Virbac Business Overview
11.17.3 Virbac Animal Antibacterial and Antibiotics Products and Services
11.17.4 Virbac Animal Antibacterial and Antibiotics Revenue in Animal Antibacterial and Antibiotics Business (2017-2022)
11.17.5 Virbac Recent Developments
11.18 Vitafor
11.18.1 Vitafor Company Details
11.18.2 Vitafor Business Overview
11.18.3 Vitafor Animal Antibacterial and Antibiotics Products and Services
11.18.4 Vitafor Animal Antibacterial and Antibiotics Revenue in Animal Antibacterial and Antibiotics Business (2017-2022)
11.18.5 Vitafor Recent Developments
12 Animal Antibacterial and Antibiotics Market Dynamics
12.1 Animal Antibacterial and Antibiotics Market Trends
12.2 Animal Antibacterial and Antibiotics Market Drivers
12.3 Animal Antibacterial and Antibiotics Market Challenges
12.4 Animal Antibacterial and Antibiotics Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
List of Tables
Table 1. Global Animal Antibacterial and Antibiotics Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Tetracyclines
Table 3. Key Players of Penicillins
Table 4. Key Players of Sulfonamides
Table 5. Key Players of Macrolides
Table 6. Key Players of Aminoglycosides
Table 7. Key Players of Cephalosporins
Table 8. Global Animal Antibacterial and Antibiotics Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 9. Global Animal Antibacterial and Antibiotics Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 10. Global Animal Antibacterial and Antibiotics Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Animal Antibacterial and Antibiotics Revenue Market Share by Region (2017-2022)
Table 12. Global Animal Antibacterial and Antibiotics Revenue by Players (2017-2022) & (US$ Million)
Table 13. Global Animal Antibacterial and Antibiotics Market Share by Players (2017-2022)
Table 14. Global Top Animal Antibacterial and Antibiotics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Animal Antibacterial and Antibiotics as of 2021)
Table 15. Ranking of Global Top Animal Antibacterial and Antibiotics Companies by Revenue (US$ Million) in 2021
Table 16. Global 5 Largest Players Market Share by Animal Antibacterial and Antibiotics Revenue (CR5 and HHI) & (2017-2022)
Table 17. Key Players Headquarters and Area Served
Table 18. Key Players Animal Antibacterial and Antibiotics Product Solution and Service
Table 19. Date of Key Manufacturers Enter into Animal Antibacterial and Antibiotics Market
Table 20. Mergers & Acquisitions, Expansion Plans
Table 21. Global Animal Antibacterial and Antibiotics Market Size by Type (2017-2022) & (US$ Million)
Table 22. Global Animal Antibacterial and Antibiotics Revenue Market Share by Type (2017-2022)
Table 23. Global Animal Antibacterial and Antibiotics Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 24. Global Animal Antibacterial and Antibiotics Revenue Market Share by Type (2023-2028)
Table 25. Global Animal Antibacterial and Antibiotics Market Size by Application (2017-2022) & (US$ Million)
Table 26. Global Animal Antibacterial and Antibiotics Revenue Market Share by Application (2017-2022)
Table 27. Global Animal Antibacterial and Antibiotics Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 28. Global Animal Antibacterial and Antibiotics Revenue Market Share by Application (2023-2028)
Table 29. North America Animal Antibacterial and Antibiotics Revenue by Company (2020-2022) & (US$ Million)
Table 30. North America Animal Antibacterial and Antibiotics Revenue by Type (2017-2022) & (US$ Million)
Table 31. North America Animal Antibacterial and Antibiotics Revenue by Type (2023-2028) & (US$ Million)
Table 32. North America Animal Antibacterial and Antibiotics Revenue by Application (2017-2022) & (US$ Million)
Table 33. North America Animal Antibacterial and Antibiotics Revenue by Application (2023-2028) & (US$ Million)
Table 34. North America Animal Antibacterial and Antibiotics Revenue by Country (2017-2022) & (US$ Million)
Table 35. North America Animal Antibacterial and Antibiotics Revenue by Country (2023-2028) & (US$ Million)
Table 36. Europe Animal Antibacterial and Antibiotics Revenue by Company (2020-2022) & (US$ Million)
Table 37. Europe Animal Antibacterial and Antibiotics Revenue by Type (2017-2022) & (US$ Million)
Table 38. Europe Animal Antibacterial and Antibiotics Revenue by Type (2023-2028) & (US$ Million)
Table 39. Europe Animal Antibacterial and Antibiotics Revenue by Application (2017-2022) & (US$ Million)
Table 40. Europe Animal Antibacterial and Antibiotics Revenue by Application (2023-2028) & (US$ Million)
Table 41. Europe Animal Antibacterial and Antibiotics Revenue by Country (2017-2022) & (US$ Million)
Table 42. Europe Animal Antibacterial and Antibiotics Revenue by Country (2023-2028) & (US$ Million)
Table 43. Asia Pacific Animal Antibacterial and Antibiotics Revenue by Company (2020-2022) & (US$ Million)
Table 44. Asia Pacific Animal Antibacterial and Antibiotics Revenue by Type (2017-2022) & (US$ Million)
Table 45. Asia Pacific Animal Antibacterial and Antibiotics Revenue by Type (2023-2028) & (US$ Million)
Table 46. Asia Pacific Animal Antibacterial and Antibiotics Revenue by Application (2017-2022) & (US$ Million)
Table 47. Asia Pacific Animal Antibacterial and Antibiotics Revenue by Application (2023-2028) & (US$ Million)
Table 48. Asia Pacific Animal Antibacterial and Antibiotics Revenue by Region (2017-2022) & (US$ Million)
Table 49. Asia Pacific Animal Antibacterial and Antibiotics Revenue by Region (2023-2028) & (US$ Million)
Table 50. Latin America Animal Antibacterial and Antibiotics Revenue by Company (2020-2022) & (US$ Million)
Table 51. Latin America Animal Antibacterial and Antibiotics Revenue by Type (2017-2022) & (US$ Million)
Table 52. Latin America Animal Antibacterial and Antibiotics Revenue by Type (2023-2028) & (US$ Million)
Table 53. Latin America Animal Antibacterial and Antibiotics Revenue by Application (2017-2022) & (US$ Million)
Table 54. Latin America Animal Antibacterial and Antibiotics Revenue by Application (2023-2028) & (US$ Million)
Table 55. Latin America Animal Antibacterial and Antibiotics Revenue by Country (2017-2022) & (US$ Million)
Table 56. Latin America Animal Antibacterial and Antibiotics Revenue by Country (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Animal Antibacterial and Antibiotics Revenue by Company (2020-2022) & (US$ Million)
Table 58. Middle East and Africa Animal Antibacterial and Antibiotics Revenue by Type (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Animal Antibacterial and Antibiotics Revenue by Type (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Animal Antibacterial and Antibiotics Revenue by Application (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Animal Antibacterial and Antibiotics Revenue by Application (2023-2028) & (US$ Million)
Table 62. Middle East and Africa Animal Antibacterial and Antibiotics Revenue by Country (2017-2022) & (US$ Million)
Table 63. Middle East and Africa Animal Antibacterial and Antibiotics Revenue by Country (2023-2028) & (US$ Million)
Table 64. Zoetis Company Details
Table 65. Zoetis Business Overview
Table 66. Zoetis Animal Antibacterial and Antibiotics Product and Services
Table 67. Zoetis Animal Antibacterial and Antibiotics Revenue in Animal Antibacterial and Antibiotics Business (2017-2022) & (US$ Million)
Table 68. Zoetis Animal Antibacterial and Antibiotics SWOT Analysis
Table 69. Zoetis Recent Developments
Table 70. Merck Animal Health Company Details
Table 71. Merck Animal Health Business Overview
Table 72. Merck Animal Health Animal Antibacterial and Antibiotics Product and Services
Table 73. Merck Animal Health Animal Antibacterial and Antibiotics Revenue in Animal Antibacterial and Antibiotics Business (2017-2022) & (US$ Million)
Table 74. Merck Animal Health Animal Antibacterial and Antibiotics SWOT Analysis
Table 75. Merck Animal Health Recent Developments
Table 76. Merial Company Details
Table 77. Merial Business Overview
Table 78. Merial Animal Antibacterial and Antibiotics Product and Services
Table 79. Merial Animal Antibacterial and Antibiotics Revenue in Animal Antibacterial and Antibiotics Business (2017-2022) & (US$ Million)
Table 80. Merial Animal Antibacterial and Antibiotics SWOT Analysis
Table 81. Merial Recent Developments
Table 82. Elanco Company Details
Table 83. Elanco Business Overview
Table 84. Elanco Animal Antibacterial and Antibiotics Product and Services
Table 85. Elanco Animal Antibacterial and Antibiotics Revenue in Animal Antibacterial and Antibiotics Business (2017-2022) & (US$ Million)
Table 86. Elanco Animal Antibacterial and Antibiotics SWOT Analysis
Table 87. Elanco Recent Developments
Table 88. Bayer HealthCare Company Details
Table 89. Bayer HealthCare Business Overview
Table 90. Bayer HealthCare Animal Antibacterial and Antibiotics Product and Services
Table 91. Bayer HealthCare Animal Antibacterial and Antibiotics Revenue in Animal Antibacterial and Antibiotics Business (2017-2022) & (US$ Million)
Table 92. Bayer HealthCare Animal Antibacterial and Antibiotics SWOT Analysis
Table 93. Bayer HealthCare Recent Developments
Table 94. Biogénesis Bagó Company Details
Table 95. Biogénesis Bagó Business Overview
Table 96. Biogénesis Bagó Animal Antibacterial and Antibiotics Product and Services
Table 97. Biogénesis Bagó Animal Antibacterial and Antibiotics Revenue in Animal Antibacterial and Antibiotics Business (2017-2022) & (US$ Million)
Table 98. Biogénesis Bagó Animal Antibacterial and Antibiotics SWOT Analysis
Table 99. Biogénesis Bagó Recent Developments
Table 100. Boehringer Ingelheim Vetmedica Company Details
Table 101. Boehringer Ingelheim Vetmedica Business Overview
Table 102. Boehringer Ingelheim Vetmedica Animal Antibacterial and Antibiotics Product and Services
Table 103. Boehringer Ingelheim Vetmedica Animal Antibacterial and Antibiotics Revenue in Animal Antibacterial and Antibiotics Business (2017-2022) & (US$ Million)
Table 104. Boehringer Ingelheim Vetmedica Animal Antibacterial and Antibiotics SWOT Analysis
Table 105. Boehringer Ingelheim Vetmedica Recent Developments
Table 106. Ceva Santé Animale Company Details
Table 107. Ceva Santé Animale Business Overview
Table 108. Ceva Santé Animale Animal Antibacterial and Antibiotics Product and Services
Table 109. Ceva Santé Animale Animal Antibacterial and Antibiotics Revenue in Animal Antibacterial and Antibiotics Business (2017-2022) & (US$ Million)
Table 110. Ceva Santé Animale Animal Antibacterial and Antibiotics SWOT Analysis
Table 111. Ceva Santé Animale Recent Developments
Table 112. Dechra Pharmaceuticals Company Details
Table 113. Dechra Pharmaceuticals Business Overview
Table 114. Dechra Pharmaceuticals Animal Antibacterial and Antibiotics Product and Services
Table 115. Dechra Pharmaceuticals Animal Antibacterial and Antibiotics Revenue in Animal Antibacterial and Antibiotics Business (2017-2022) & (US$ Million)
Table 116. Dechra Pharmaceuticals Animal Antibacterial and Antibiotics SWOT Analysis
Table 117. Dechra Pharmaceuticals Recent Developments
Table 118. ECO Animal Health Company Details
Table 119. ECO Animal Health Business Overview
Table 120. ECO Animal Health Animal Antibacterial and Antibiotics Product and Services
Table 121. ECO Animal Health Animal Antibacterial and Antibiotics Revenue in Animal Antibacterial and Antibiotics Business (2017-2022) & (US$ Million)
Table 122. ECO Animal Health Animal Antibacterial and Antibiotics SWOT Analysis
Table 123. ECO Animal Health Recent Developments
Table 124. Huvepharma Company Details
Table 125. Huvepharma Business Overview
Table 126. Huvepharma Animal Antibacterial and Antibiotics Product and Services
Table 127. Huvepharma Animal Antibacterial and Antibiotics Revenue in Animal Antibacterial and Antibiotics Business (2017-2022) & (US$ Million)
Table 128. Huvepharma Recent Developments
Table 129. Neogen Company Details
Table 130. Neogen Business Overview
Table 131. Neogen Animal Antibacterial and Antibiotics Product and Services
Table 132. Neogen Animal Antibacterial and Antibiotics Revenue in Animal Antibacterial and Antibiotics Business (2017-2022) & (US$ Million)
Table 133. Neogen Recent Developments
Table 134. Norbrook Company Details
Table 135. Norbrook Business Overview
Table 136. Norbrook Animal Antibacterial and Antibiotics Product and Services
Table 137. Norbrook Animal Antibacterial and Antibiotics Revenue in Animal Antibacterial and Antibiotics Business (2017-2022) & (US$ Million)
Table 138. Norbrook Recent Developments
Table 139. Orion Company Details
Table 140. Orion Business Overview
Table 141. Orion Animal Antibacterial and Antibiotics Product and Services
Table 142. Orion Animal Antibacterial and Antibiotics Revenue in Animal Antibacterial and Antibiotics Business (2017-2022) & (US$ Million)
Table 143. Orion Recent Developments
Table 144. Phibro Animal Health Company Details
Table 145. Phibro Animal Health Business Overview
Table 146. Phibro Animal Health Animal Antibacterial and Antibiotics Product and Services
Table 147. Phibro Animal Health Animal Antibacterial and Antibiotics Revenue in Animal Antibacterial and Antibiotics Business (2017-2022) & (US$ Million)
Table 148. Phibro Animal Health Recent Developments
Table 149. Vétoquinol Company Details
Table 150. Vétoquinol Business Overview
Table 151. Vétoquinol Animal Antibacterial and Antibiotics Product and Services
Table 152. Vétoquinol Animal Antibacterial and Antibiotics Revenue in Animal Antibacterial and Antibiotics Business (2017-2022) & (US$ Million)
Table 153. Vétoquinol Recent Developments
Table 154. Virbac Company Details
Table 155. Virbac Business Overview
Table 156. Virbac Animal Antibacterial and Antibiotics Product and Services
Table 157. Virbac Animal Antibacterial and Antibiotics Revenue in Animal Antibacterial and Antibiotics Business (2017-2022) & (US$ Million)
Table 158. Virbac Recent Developments
Table 159. Vitafor Company Details
Table 160. Vitafor Business Overview
Table 161. Vitafor Animal Antibacterial and Antibiotics Product and Services
Table 162. Vitafor Animal Antibacterial and Antibiotics Revenue in Animal Antibacterial and Antibiotics Business (2017-2022) & (US$ Million)
Table 163. Vitafor Recent Developments
Table 164. Animal Antibacterial and Antibiotics Market Trends
Table 165. Animal Antibacterial and Antibiotics Market Drivers
Table 166. Animal Antibacterial and Antibiotics Market Challenges
Table 167. Animal Antibacterial and Antibiotics Market Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Animal Antibacterial and Antibiotics Sales Market Share by Type: 2021 VS 2028
Figure 2. Tetracyclines Features
Figure 3. Penicillins Features
Figure 4. Sulfonamides Features
Figure 5. Macrolides Features
Figure 6. Aminoglycosides Features
Figure 7. Cephalosporins Features
Figure 8. Global Animal Antibacterial and Antibiotics Sales Market Share by Application: 2021 VS 2028
Figure 9. Livestock Case Studies
Figure 10. Pets Case Studies
Figure 11. Others Case Studies
Figure 12. Animal Antibacterial and Antibiotics Report Years Considered
Figure 13. Global Animal Antibacterial and Antibiotics Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Animal Antibacterial and Antibiotics Market Size 2017-2028 (US$ Million)
Figure 15. Global Animal Antibacterial and Antibiotics Market Size Market Share by Region: 2021 VS 2028
Figure 16. Global Animal Antibacterial and Antibiotics Revenue Market Share by Region in 2017 VS 2022
Figure 17. Global Top 10 Animal Antibacterial and Antibiotics Countries Ranking by Market Size (US$ Million) in 2021
Figure 18. Global Animal Antibacterial and Antibiotics Market Share by Players in 2021
Figure 19. Global Top Animal Antibacterial and Antibiotics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Animal Antibacterial and Antibiotics as of 2021)
Figure 20. The Top 10 and 5 Players Market Share by Animal Antibacterial and Antibiotics Revenue in 2021
Figure 21. North America Animal Antibacterial and Antibiotics Revenue Market Share by Company in 2021
Figure 22. North America Animal Antibacterial and Antibiotics Revenue Market Share by Type (2017-2028)
Figure 23. North America Animal Antibacterial and Antibiotics Revenue Market Share by Application (2017-2028)
Figure 24. North America Animal Antibacterial and Antibiotics Revenue Share by Country (2017-2028)
Figure 25. U.S. Animal Antibacterial and Antibiotics Revenue (2017-2028) & (US$ Million)
Figure 26. Canada Animal Antibacterial and Antibiotics Revenue (2017-2028) & (US$ Million)
Figure 27. Europe Animal Antibacterial and Antibiotics Revenue Market Share by Company in 2021
Figure 28. Europe Animal Antibacterial and Antibiotics Revenue Market Share by Type (2017-2028)
Figure 29. Europe Animal Antibacterial and Antibiotics Revenue Market Share by Application (2017-2028)
Figure 30. Europe Animal Antibacterial and Antibiotics Revenue Share by Country (2017-2028)
Figure 31. Germany Animal Antibacterial and Antibiotics Revenue (2017-2028) & (US$ Million)
Figure 32. France Animal Antibacterial and Antibiotics Revenue (2017-2028) & (US$ Million)
Figure 33. U.K. Animal Antibacterial and Antibiotics Revenue (2017-2028) & (US$ Million)
Figure 34. Italy Animal Antibacterial and Antibiotics Revenue (2017-2028) & (US$ Million)
Figure 35. Russia Animal Antibacterial and Antibiotics Revenue (2017-2028) & (US$ Million)
Figure 36. Asia Pacific Animal Antibacterial and Antibiotics Revenue Market Share by Company in 2021
Figure 37. Asia Pacific Animal Antibacterial and Antibiotics Revenue Market Share by Type (2017-2028)
Figure 38. Asia Pacific Animal Antibacterial and Antibiotics Revenue Market Share by Application (2017-2028)
Figure 39. Asia Pacific Animal Antibacterial and Antibiotics Revenue Share by Region (2017-2028)
Figure 40. China Animal Antibacterial and Antibiotics Revenue (2017-2028) & (US$ Million)
Figure 41. Japan Animal Antibacterial and Antibiotics Revenue (2017-2028) & (US$ Million)
Figure 42. South Korea Animal Antibacterial and Antibiotics Revenue (2017-2028) & (US$ Million)
Figure 43. India Animal Antibacterial and Antibiotics Revenue (2017-2028) & (US$ Million)
Figure 44. Australia Animal Antibacterial and Antibiotics Revenue (2017-2028) & (US$ Million)
Figure 45. Taiwan Animal Antibacterial and Antibiotics Revenue (2017-2028) & (US$ Million)
Figure 46. Indonesia Animal Antibacterial and Antibiotics Revenue (2017-2028) & (US$ Million)
Figure 47. Thailand Animal Antibacterial and Antibiotics Revenue (2017-2028) & (US$ Million)
Figure 48. Malaysia Animal Antibacterial and A
Global Animal Antibacterial and Antibiotics Market Growth (Status and Outlook) 2022-2028
As the global economy mends, the 2021 growth of Animal Antibacterial and Antibiotics will have significant change from previous year. According to our (LP Information) latest study, the global Animal Antibacterial and Antibiotics market size is USD m... |
Global Animal Antibacterial And Antibiotics Market Research Report with Opportunities and Strategies to Boost Growth- COVID-19 Impact and Recovery
Animal Antibacterial and Antibiotics are usually used in animal feed, antibiotic use whether for therapy or prevention of bacterial diseases, or as performance enhancers will result in antibiotic resistant micro-organisms, not only among pathogens bu... |
Buy Any Report Avail 25% Discount.
Coupon Code: DIS25